Bank of Hawaii’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $270K | Buy |
+1,720
| New | +$258K | 0.01% | 212 |
|
|
2022
Q3 | – | Sell |
-4,152
| Closed | -$351K | – | 251 |
|
|
2022
Q2 | $351K | Buy |
4,152
+79
| +2% | +$6.93K | 0.02% | 200 |
|
|
2022
Q1 | $357K | Buy |
4,073
+624
| +18% | +$54K | 0.02% | 213 |
|
|
2021
Q4 | $302K | Sell |
3,449
-144
| -4% | -$12K | 0.02% | 224 |
|
|
2021
Q3 | $294K | Sell |
3,593
-1,002
| -22% | -$90.1K | 0.02% | 225 |
|
|
2021
Q2 | $419K | Sell |
4,595
-994
| -18% | -$88.5K | 0.02% | 217 |
|
|
2021
Q1 | $478K | Buy |
5,589
+570
| +11% | +$51.2K | 0.03% | 209 |
|
|
2020
Q4 | $474K | Buy |
5,019
+980
| +24% | +$85.6K | 0.03% | 203 |
|
|
2020
Q3 | $351K | Buy |
+4,039
| New | +$350K | 0.03% | 214 |
|
|
2019
Q2 | – | Sell |
-3,475
| Closed | -$299K | – | 335 |
|
|
2019
Q1 | $299K | Sell |
3,475
-963
| -22% | -$77.3K | 0.02% | 275 |
|
|
2018
Q4 | $341K | Sell |
4,438
-4,968
| -53% | -$387K | 0.03% | 272 |
|
|
2018
Q3 | $726K | Sell |
9,406
-1,641
| -15% | -$121K | 0.06% | 214 |
|
|
2018
Q2 | $748K | Sell |
11,047
-5,434
| -33% | -$375K | 0.06% | 189 |
|
|
2018
Q1 | $1.19M | Sell |
16,481
-2,464
| -13% | -$188K | 0.1% | 140 |
|
|
2017
Q4 | $1.43M | Sell |
18,945
-342
| -2% | -$25.8K | 0.12% | 129 |
|
|
2017
Q3 | $1.48M | Sell |
19,287
-8,592
| -31% | -$649K | 0.13% | 125 |
|
|
2017
Q2 | $2.08M | Sell |
27,879
-6,556
| -19% | -$465K | 0.18% | 97 |
|
|
2017
Q1 | $2.29M | Buy |
34,435
+6,851
| +25% | +$457K | 0.21% | 90 |
|
|
2016
Q4 | $1.8M | Buy |
27,584
+19,038
| +223% | +$1.23M | 0.17% | 103 |
|
|
2016
Q3 | $604K | Sell |
8,546
-220
| -3% | -$16K | 0.06% | 207 |
|
|
2016
Q2 | $648K | Sell |
8,766
-1,404
| -14% | -$97K | 0.07% | 201 |
|
|
2016
Q1 | $660K | Sell |
10,170
-1,622
| -14% | -$110K | 0.07% | 197 |
|
|
2015
Q4 | $909K | Sell |
11,792
-3,097
| -21% | -$246K | 0.1% | 168 |
|
|
2015
Q3 | $1.23M | Sell |
14,889
-283
| -2% | -$25.2K | 0.14% | 139 |
|
|
2015
Q2 | $1.34M | Buy |
15,172
+94
| +0.6% | +$8.62K | 0.14% | 143 |
|
|
2015
Q1 | $1.33M | Buy |
15,078
+290
| +2% | +$25.7K | 0.13% | 154 |
|
|
2014
Q4 | $1.23M | Sell |
14,788
-689
| -4% | -$57.1K | 0.11% | 158 |
|
|
2014
Q3 | $1.3M | Buy |
15,477
+39
| +0.3% | +$3.15K | 0.12% | 143 |
|
|
2014
Q2 | $1.25M | Buy |
15,438
+1,968
| +15% | +$155K | 0.12% | 149 |
|
|
2014
Q1 | $1.03M | Buy |
13,470
+744
| +6% | +$54.2K | 0.1% | 176 |
|
|
2013
Q4 | $917K | Buy |
12,726
+177
| +1% | +$12.3K | 0.09% | 181 |
|
|
2013
Q3 | $863K | Buy |
12,549
+641
| +5% | +$42.4K | 0.09% | 177 |
|
|
2013
Q2 | $754K | Buy |
+11,908
| New | +$775K | 0.08% | 180 |
|
Other funds holding NVS
Bank of Hawaii's NVS Position: Q2 2026 in Review
Bank of Hawaii opened a new position in Novartis (NVS) in Q2 2026: 1,720 shares worth $270K. The stake represents 0.01% of the portfolio and ranks #212 among its holdings. This is a return to the name: Bank of Hawaii previously reported a position in NVS as recently as Q2 2022.
Bank of Hawaii first reported a position in NVS in Q2 2013 and has held it in 33 quarters since. The position peaked at $2.29M in Q1 2017. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Bank of Hawaii held 1,720 shares of Novartis worth $270K as of Q2 2026.
- Novartis was a new Bank of Hawaii position in Q2 2026.
- Novartis made up 0.01% of Bank of Hawaii's portfolio in Q2 2026, its #212 holding.
- Bank of Hawaii first reported a position in Novartis in Q2 2013 and has held it in 33 quarters since.
- Bank of Hawaii's Novartis position peaked at $2.29M in Q1 2017.
- 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Bank of Hawaii's 13F filing for Q2 2026, filed 14 Aug 2026.